Ghent University Academic Bibliography

A practical approach to clinical antibiotic stewardship in the ICU patient with severe infection

Jan Fierens (UGent) , Pieter Depuydt (UGent) and Jan De Waele (UGent)

(2019) SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 40(4). p.435-446

Journal Article
A1
open access

Pneumococcal carriage, serotype distribution and risk factors in children with community-acquired pneumonia, 5 years after introduction of the 10-valent pneumococcal conjugate vaccine in Ethiopia

Abel Abera Negash (UGent) , Daniel Asrat, Workeabeba Abebe, Tewodros Hailemariam, Meseret Gebre, Jan Verhaegen, Abraham Aseffa and Mario Vaneechoutte (UGent)

(2019) OPEN FORUM INFECTIOUS DISEASES. 6(6).

Add to list

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

David Villafuerte, Stefano Aliberti, Nilam J. Soni, Paola Faverio, Pedro J. Marcos, Richard G. Wunderink, Alejandro Rodriguez, Oriol Sibila, Francisco Sanz, Ignacio Martin‐Loeches, et al.

(2019) RESPIROLOGY. 25(5). p.543-551

Add to list

Methicillin-resistant staphylococcus aureus pneumonia in older people : a diagnostic and therapeutic challenge

Maja Kiselinova (UGent) , Anja Velghe (UGent) , Ruth Piers (UGent) , Bruno Verhasselt (UGent) and Nele Van Den Noortgate (UGent)

(2019) ACTA CLINICA BELGICA. 74(6). p.456-459

Add to list

International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

Stefano Aliberti, Grayden S. Cook, Bettina L. Babu, Luis F. Reyes, Alejandro H. Rodriguez, Francisco Sanz, Nilam J. Soni, Antonio Anzueto, Paola Faverio, Ricardo Franco Sadud, et al.

(2019) JOURNAL OF INFECTION. 79(4). p.300-311

Add to list

Optimising experimental research in respiratory diseases : an ERS statement

Philippe Bonniaud, Aurelie Fabre, Nelly Frossard, Christophe Guignabert, Mark Inman, Wolfgang M Kuebler, Tania Maes (UGent) , Wei Shi, Martin Stampfli, Stefan Uhlig, et al.

(2018) EUROPEAN RESPIRATORY JOURNAL. 51(5).

Add to list

Toxicity of long-term use of proton pump inhibitors in children

Pauline De Bruyne (UGent) and Shinya Ito

(2018) ARCHIVES OF DISEASE IN CHILDHOOD. 103(1). p.78-82

Add to list

To which extent can we decrease antibiotic duration in critically ill patients?

José Garnacho-Montero, Angel Arenzana-Seisdedos, Jan De Waele (UGent) and Marin H Kollef

(2017) EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 10(11). p.1215-1223

Add to list

Hyperleptinemia is associated with impaired pulmonary host defense

Niki DJ Ubags, Renee D Stapleton, Juanita H.J. Vernooy, Elianne Burg (UGent) , Jenna Bement, Catherine M Hayes, Sebastian Ventrone, Lennart Zabeau (UGent) , Jan Tavernier (UGent) , Matthew E Poynter, et al.

(2016) JCI INSIGHT. 1(8).

Add to list

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Ioanna Christopoulou (UGent) , Kenny Roose (UGent) , Lorena Ibanez (UGent) and Xavier Saelens (UGent)

(2015) EXPERT REVIEW OF VACCINES. 14(1). p.55-67

Academic Bibliography

A practical approach to clinical antibiotic stewardship in the ICU patient with severe infection

Pneumococcal carriage, serotype distribution and risk factors in children with community-acquired pneumonia, 5 years after introduction of the 10-valent pneumococcal conjugate vaccine in Ethiopia

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

Methicillin-resistant staphylococcus aureus pneumonia in older people : a diagnostic and therapeutic challenge

International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

Optimising experimental research in respiratory diseases : an ERS statement

Toxicity of long-term use of proton pump inhibitors in children

To which extent can we decrease antibiotic duration in critically ill patients?

Hyperleptinemia is associated with impaired pulmonary host defense

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Contents

Support

Contact